Inventor · disambiguated record
Jayachandra P. Reddy
Also filed as: REDDY JAYACHANDRA P
4 granted patents·17 pending applications·10 citations·filing 2019–2024
68Inventor score
Files withCRINETICS PHARMACEUTICALS INC7SANDHILL ONE LLC7XINTHERA INC3KINNATE BIOPHARMA INC2SOJOURNIX INC2
Top patents by PatentIndex Score
21 records- 0185US10464918B2Process of making somatostatin modulatorsCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Nov 5, 2019·6 cites·24 claims
- 0283US10889561B2Process of making somatostatin modulatorsCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Jan 12, 2021·3 cites·10 claims
- 0380US11773076B2Crystalline forms of a somatostatin modulatorCRINETICS PHARMACEUTICALS INC·Filed 2022·Granted Oct 3, 2023·1 cites·29 claims
- 0474US2024376067A1Process of making somatostatin modulatorsCRINETICS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0565US2024208963A1Crystalline melanocortin subtype-2 receptor (mc2r) antagonistCRINETICS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0664US2021087165A1Process of making somatostatin modulatorsCRINETICS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0763US2024182449A1Crystalline forms of an mk2 inhibitorXINTHERA INC·Filed 2023·Application pending·0 cites
- 0862US2024174669A1Crystalline forms of a parp1 inhibitorXINTHERA INC·Filed 2023·Application pending·0 cites
- 0960US2025059170A1Solid state forms of an fgfr inhibitorKINNATE BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1058US2024208931A1Solid state forms of (s)-n-(3-(2-(((r)-1-hydroxypropan-2-yl)amino)-6-morpholinopyridin-4-yl)-4-methylphenyl)-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and salts thereofKINNATE BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1156US2024317746A1Crystalline forms of an azetidine parp1 inhibitorXINTHERA INC·Filed 2024·Application pending·0 cites
- 1250US2025296949A1High purity non-animal derived udcaSANDHILL ONE LLC·Filed 2022·Application pending·0 cites
- 1348US2025188113A1High purity non-animal derived tudcaSANDHILL ONE LLC·Filed 2022·Application pending·0 cites
- 1447US2023416800A1Enzymatic methods for converting lca and 3-kca to udca and 3-kudcaSANDHILL ONE LLC·Filed 2021·Application pending·0 cites
- 1545US2024425544A1Stereoselective steroidal reductionsSANDHILL ONE LLC·Filed 2022·Application pending·0 cites
- 1645US2022298202A1Methods of making cholic acid derivatives and starting materials thereforSANDHILL ONE LLC·Filed 2022·Application pending·0 cites
- 1744US11384116B2Methods of making cholic acid derivatives and starting materials thereforSANDHILL ONE LLC·Filed 2021·Granted Jul 12, 2022·0 cites·17 claims
- 1844US2022267295A1Crystalline forms of somatostatin modulatorsCRINETICS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1942US2024102073A1Genetically modified organisms for the production of steroid derivativesSANDHILL ONE LLC·Filed 2021·Application pending·0 cites
- 2040US2020216396A1Deuterated forms of isoquinolinone and methods of use thereofSOJOURNIX INC·Filed 2020·Application pending·0 cites
- 2136US2021371385A1Polymorphic and amorphous forms of isoquinolinone and methods of use thereofSOJOURNIX INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jayachandra P. Reddy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →